Covered recipient · General Payments record
BALAGOPALAN ACHUTHAN NAIR
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$438.68
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $139.80 | 3 |
| Food and Beverage | $119.72 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $99.99 | 1 |
| Acerta Pharma LLC | $43.52 | 2 |
| Gilead Sciences, Inc. | $38.05 | 2 |
| Daiichi Sankyo Inc. | $37.24 | 2 |
| Lilly USA, LLC | $15.36 | 1 |
| PFIZER INC. | $13.86 | 1 |
| Rigel Pharmaceuticals, Inc. | $11.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $17.57 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105608041 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.95 | 11/18/2024 | Education | Undisputed | 01/23/2026 | 1105486873 | CMS |
| Daiichi Sankyo Inc. | $19.70 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089461325 | CMS |
| Daiichi Sankyo Inc. | $17.54 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089461343 | CMS |
| Gilead Sciences, Inc. | $14.39 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133802280 | CMS |
| Gilead Sciences, Inc. | $23.66 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133802282 | CMS |
| Janssen Biotech, Inc. | $99.99 | 08/12/2024 | Education | Undisputed | 01/23/2026 | 1078270045 | CMS |
| Lilly USA, LLC | $15.36 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136061052 | CMS |
| PFIZER INC. | $13.86 | 09/12/2024 | Education | Undisputed | 01/23/2026 | 1132059076 | CMS |
| Rigel Pharmaceuticals, Inc. | $11.50 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145198601 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.